New Voyages to Carolina : Reinterpreting North Carolina History

Autor: Larry E. Tise, Jeffrey J. Crow

New Voyages to Carolina offers a bold new approach for understanding and telling North Carolina's history. Recognizing the need for such a fresh approach and reflecting a generation of recent scholarship, eighteen distinguished authors have sculpted

Delineating the epilepsy phenotype of NRROS-related microgliopathy: A case report and literature review

Autor: Priyanka Madaan, Yashovardhan Kaushal, Priyanka Srivastava, Yanick J Crow, John H Livingston, Chirag Ahuja, Naveen Sankhyan

Publikováno v: Madaan, P, Kaushal, Y, Srivastava, P, Crow, Y J, Livingston, J H, Ahuja, C & Sankhyan, N 2022, ' Delineating the epilepsy phenotype of NRROS-related microgliopathy: a case report and literature review ', Seizure-European Journal of Epilepsy . https://doi.org/10.1016/j.seizure.2022.06.001

Background: Negative regulator of reactive oxygen species (NRROS) related microgliopathy, a rare and recently recognized neurodegenerative condition, is caused by pathogenic variants in the NRROS gene, which plays a major role in the regulation of tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3ef854c91b0c16eac858c43fe34d38c
https://doi.org/10.1016/j.seizure.2022.06.001

JAK inhibition in Aicardi-Goutières syndrome: a monocentric multidisciplinary real-world approach study

Autor: Marie-Louise Frémond, Marie Hully, Benjamin Fournier, Rémi Barrois, Romain Lévy, Mélodie Aubart, Martin Castelle, Delphine Chabalier, Clarisse Gins, Eugénie Sarda, Buthaina Al Adba, Sophie Couderc, Céline D’ Almeida, Claire-Marine Berat, Chloé Durrleman, Caroline Espil, Laetitia Lambert, Cécile Méni, Maximilien Périvier, Pascal Pillet, Laura Polivka, Manuel Schiff, Calina Todosi, Florence Uettwiller, Alice Lepelley, Gillian I. Rice, Luis Seabra, Sylvia Sanquer, Anne Hulin, Claire Pressiat, Lauriane Goldwirt, Vincent Bondet, Darragh Duffy, Despina Moshous, Brigitte Bader-Meunier, Christine Bodemer, Florence Robin-Renaldo, Nathalie Boddaert, Stéphane Blanche, Isabelle Desguerre, Yanick J. Crow, Bénédicte Neven

Publikováno v: Frémond, M-L, Hully, M, Fournier, B, Barrois, R, Lévy, R, Aubart, M, Castelle, M, Chabalier, D, Gins, C, Sarda, E, Al Adba, B, Couderc, S, D'Almeida, C, Berat, C-M, Durrleman, C, Espil, C, Lambert, L, Meni, C, Perivier, M, Pillet, P, Polivka, L, Schiff, M, Todosi, C, Uettwiller, F, Lepelley, A, Rice, G I, Seabra, L, Sanquer, S, Hulin, A, Pressiat, C, Goldwirt, L, Bondet, V, Duffy, D, Moshous, D, Bader-Meunier, B, Bodemer, C, Robin-Renaldo, F, Boddaert, N, Blanche, S, Desguerre, I, Crow, Y J & Neven, B 2023, ' JAK inhibition in Aicardi-Goutières syndrome: a monocentric multidisciplinary real-world approach study ', Journal of Clinical Immunology . https://doi.org/10.1007/s10875-023-01500-z
Journal of Clinical Immunology
Journal of Clinical Immunology, 2023, ⟨10.1007/s10875-023-01500-z⟩

The paradigm type I interferonopathy Aicardi-Goutières syndrome (AGS) is most typically characterized by severe neurological involvement. AGS is considered an immune-mediated disease, poorly responsive to conventional immunosuppression. Premised on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58d11f3ba2d92b02045d598c8be04f08
https://www.pure.ed.ac.uk/ws/files/342033048/Cohort_MAIN_R1_vDEF_Unmarked.docx

Terminal anorexia nervosa cannot currently be identified

Autor: Scott J. Crow

Publikováno v: International Journal of Eating Disorders.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b3cd4226267d0354dfb5008dd904f7d1
https://doi.org/10.1002/eat.23957

Type I interferon–related kidney disorders

Autor: Lorenzo Lodi, Maria V. Mastrolia, Federica Bello, Giovanni M. Rossi, Maria L. Angelotti, Yanick J. Crow, Paola Romagnani, Augusto Vaglio

Publikováno v: Lodi, L, Mastrolia, M V, Bello, F, Rossi, G M, Angelotti, M L, Crow, Y J, Romagnani, P & Vaglio, A 2022, ' Type I interferon-related kidney disorders ', Kidney International, vol. 101, no. 6, pp. 1142-1159 . https://doi.org/10.1016/j.kint.2022.02.031

Type I interferon (IFN-I) mediates tissue damage in a wide range of kidney disorders, directly affecting the biology and function of several renal cell types including podocytes, mesangial, endothelial, and parietal epithelial cells. Enhanced IFN-I s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ecee32892a073ffa82ac17eab1c61d0
https://doi.org/10.1016/j.kint.2022.02.031